Cargando…
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
Autores principales: | Hunger, Aline, Medrano, Ruan FV, Strauss, Bryan E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520721/ https://www.ncbi.nlm.nih.gov/pubmed/28492558 http://dx.doi.org/10.1038/cddis.2017.201 |
Ejemplares similares
-
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma()()
por: Catani, João Paulo Portela, et al.
Publicado: (2016) -
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017) -
Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
por: Strauss, Bryan E, et al.
Publicado: (2018) -
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
por: Medrano, Ruan F.V., et al.
Publicado: (2017) -
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
por: Medrano, Ruan F. V., et al.
Publicado: (2022)